These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6812506)

  • 1. Valproic acid and immune thrombocytopenia.
    Barr RD; Copeland SA; Stockwell ML; Morris N; Kelton JC
    Arch Dis Child; 1982 Sep; 57(9):681-4. PubMed ID: 6812506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased platelet count in children with epilepsy treated with valproate and its relationship to the immature platelet fraction.
    Kurahashi H; Takami A; Murotani K; Numoto S; Okumura A
    Int J Hematol; 2018 Jan; 107(1):105-111. PubMed ID: 28879549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombocyte values during ergenyl treatment].
    Stolzis L; Scheffner D
    Bibl Psychiatr; 1975; (151):161-5. PubMed ID: 1098651
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of thrombocytopenia with antiplatelet autoantibody after sodium valproate administration--with statistical analysis of 33 cases administrated sodium valproate].
    Terui T; Ktda K; Mitani T; Terada S; Kure T; Takamura H; Hirayama M; Niitsu Y; Nakazawa O
    Rinsho Ketsueki; 1987 Jun; 28(6):865-71. PubMed ID: 3118077
    [No Abstract]   [Full Text] [Related]  

  • 5. Valproate-associated coagulopathies are frequent and variable in children.
    Attilakos A; Katsarou E; Voudris K; Garoufi A
    Epilepsia; 2007 Jan; 48(1):205-6. PubMed ID: 17241231
    [No Abstract]   [Full Text] [Related]  

  • 6. Valproic acid and thrombocytopenia: cross-sectional study.
    Ko CH; Kong CK; Tse PW
    Hong Kong Med J; 2001 Mar; 7(1):15-21. PubMed ID: 11406671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The platelet aggregation in children with epilepsy receiving valproic acid.
    Tanindi S; Akin R; Koseoglu V; Kurekci AE; Gokcay E; Ozcan O
    Thromb Res; 1996 Feb; 81(4):471-6. PubMed ID: 8907296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytopenia in pediatric patients on concurrent cannabidiol and valproic acid.
    McNamara NA; Dang LT; Sturza J; Ziobro JM; Fedak Romanowski EM; Smith GC; Joshi SM; Leber SM; Carlson M; Robertson P; Shellhaas RA
    Epilepsia; 2020 Aug; 61(8):e85-e89. PubMed ID: 32614070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic Acid-related anticonvulsant hypersensitivity syndrome and subsequent olanzapine-related neutropenia and thrombocytopenia: a case report.
    Lin YH; Chien YL
    J Clin Psychopharmacol; 2012 Feb; 32(1):132-3. PubMed ID: 22217947
    [No Abstract]   [Full Text] [Related]  

  • 11. EDTA-dependent pseudothrombocytopenia induced by valproic acid.
    Yoshikawa H
    Neurology; 2003 Aug; 61(4):579-80. PubMed ID: 12939450
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe, isolated thrombocytopenia under polytherapy with carbamazepine and valproate.
    Finsterer J; Pelzl G; Hess B
    Psychiatry Clin Neurosci; 2001 Aug; 55(4):423-6. PubMed ID: 11442896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium valproate and platelet-count.
    Raworth RE; Birchall G
    Lancet; 1978 Mar; 1(8065):670-1. PubMed ID: 76214
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of valproate therapy on thrombin generation determined by calibrated automated thrombography.
    Topf HG; Lischetzki G; Trollmann R; Rascher W; Rauh M
    Klin Padiatr; 2011 May; 223(3):165-8. PubMed ID: 21472635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation abnormalities and acquired von Willebrand's disease type 1 in children receiving valproic acid.
    Serdaroglu G; Tütüncüoglu S; Kavakli K; Tekgül H
    J Child Neurol; 2002 Jan; 17(1):41-3. PubMed ID: 11913569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgM platelet autoantibody due to sodium valproate.
    Sandler RM; Emberson C; Roberts GE; Voak D; Darnborough J; Heeley AF
    Br Med J; 1978 Dec; 2(6153):1683-4. PubMed ID: 367512
    [No Abstract]   [Full Text] [Related]  

  • 17. Valproic acid therapy in childhood epilepsy.
    Coulter DL; Wu H; Allen RJ
    JAMA; 1980 Aug 22-29; 244(8):785-8. PubMed ID: 6771426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical irrelevance of the hematologic side effects of sodium valproate (Depakine)].
    Loisseau P; Martínez-Lage JM
    Rev Med Univ Navarra; 1981 Sep; 25(3):14-6. PubMed ID: 6803320
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombocytopenia secondary to high valproate levels in children with epilepsy.
    Delgado MR; Riela AR; Mills J; Browne R; Roach ES
    J Child Neurol; 1994 Jul; 9(3):311-4. PubMed ID: 7930412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium valproate and platelet counts.
    Eastham RD; Jancar J
    Br Med J; 1980 Jan; 280(6208):186. PubMed ID: 6766772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.